HomeW2J • FRA
add
Carisma Therapeutics Inc
Previous close
€0.17
Day range
€0.14 - €0.15
Year range
€0.14 - €1.34
Market cap
6.89M USD
Avg Volume
137.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 3.73M | 9.77% |
Operating expense | 13.06M | 139.91% |
Net income | -9.27M | 51.18% |
Net profit margin | -248.48 | 55.52% |
Earnings per share | -0.22 | 52.17% |
EBITDA | -8.67M | 51.32% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.74M | -86.67% |
Total assets | 15.95M | -78.38% |
Total liabilities | 52.62M | -16.35% |
Total equity | -36.66M | — |
Shares outstanding | 41.79M | — |
Price to book | -0.19 | — |
Return on assets | -100.56% | — |
Return on capital | 78.09% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -9.27M | 51.18% |
Cash from operations | -10.07M | 55.11% |
Cash from investing | 524.00K | 3,182.35% |
Cash from financing | -626.00K | -146.30% |
Net change in cash | -10.17M | 51.78% |
Free cash flow | -11.90M | 17.03% |
About
Founded
2008
Headquarters
Website
Employees
46
